Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose
- PMID: 17044449
Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose
Abstract
Objective: Absorption profiling of cyclosporine is a current concept of drug monitoring. A single blood concentration measurement 2 hours after cyclosporine administration (C2) has been shown to be a good predictor of drug exposure and clinical outcome. The recommendation states that achieving the recommended target level of 1700 +/- 340 ng/ml within 3-5 days after renal transplantation is associated with a lower rate of acute rejection and nephrotoxicity. The high variation of pharmacokinetic profile and short limited time during early post-transplantation period make it hard to adjust the cyclosporine dose that can reach that target level on time. The present study was designed to be a method to predict the optimal pre-transplant CsA dose.
Material and method: Eleven living-related kidney transplant recipients were recruited to receive cyclosporine and were monitored for C2 concentration during the 2 weeks before operation by the designed method. The pre-transplant empirical dose of 3.5 mg/kg/dose every 12 hours were assigned to all patients. The first predicted dose was estimated by using C2 concentration of 1,700 ng/mL. The first predicted dose was prescribed to the patients. The second predicted dose was estimated by using C2 concentration of the first predicted dose. All patients received the average of the first and the second predicted doses of cyclosporine within 12-24 hrs before transplantation and until the 3rd day after transplantation.
Results: Nine out of 11 patients (81.81%) reached the target C2 level on the 3rd day after transplantation without any serious side effect and complications. The most common side effect was nausea and a flushing sensation that usually abated with a later dose after transplantation.
Conclusion: The early postoperative optimal cyclosporine dose can be effectively predicted by pre-transplant C2 measurement as conducted in the present study.
Similar articles
-
Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.J Med Assoc Thai. 2006 Aug;89 Suppl 2:S228-34. J Med Assoc Thai. 2006. PMID: 17044476
-
Limitations of C2 monitoring in renal transplant recipients.Nephrol Dial Transplant. 2005 Jul;20(7):1463-70. doi: 10.1093/ndt/gfh819. Epub 2005 Apr 19. Nephrol Dial Transplant. 2005. PMID: 15840681
-
Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.Transplant Proc. 2009 Jan-Feb;41(1):127-30. doi: 10.1016/j.transproceed.2008.11.002. Transplant Proc. 2009. PMID: 19249495
-
C2 monitoring of cyclosporine in de novo liver transplant recipients: the clinician's perspective.Liver Transpl. 2004 May;10(5):577-83. doi: 10.1002/lt.20112. Liver Transpl. 2004. PMID: 15108248 Review.
-
Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.Clin Biochem. 2004 Jun;37(6):424-8. doi: 10.1016/j.clinbiochem.2004.04.001. Clin Biochem. 2004. PMID: 15183289 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous